Data / Form D filings / Khaya Biosciences, Inc.
Khaya Biosciences, Inc.: Form D filing
Khaya Biosciences, Inc., a biotechnology company in Dothan, AL, filed a Form D with the SEC in 2026. The latest, on August 13, 2026, reports $200,000 sold of a $850,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 122 MUSEUM DRIVE ST. 221, Dothan, AL, 36303
- Phone
- (612) 965-3081
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- New York
- Year incorporated
- 2025
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2150248
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | New notice | $850,000 | $200,000 | $650,000 | 2 | Feb 5, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Garcia Sebastian | Executive Officer, Director |
Every Form D from the week of Aug 10, 2026 · All recent filings in Alabama · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Khaya Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.